Clinical Trial

A Study of HDM2005 in Patients With Advanced Solid Tumor

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a study evaluating the efficacy, safety, and pharmacokinetics ofHDM2005 in participants with metastatic solid tumors.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-27.
Trial Details
NCT Number NCT07004296
Lead Sponsor Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Conditions Advanced Solid Tumors
Enrollment 72 participants
Start Date 2025-05-29
Primary Completion 2027-07-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-08